Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pulmonary Embolism × apixaban × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 5 Other hematologic neoplasm 2 Plasma cell 1 Lymphoid 1 Gastrointestinal 1

Conditions

Lymphoma 2 Venous Thromboembolism 1 Pulmonary Embolism 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Leukemia 1 Hematologic Neoplasms 1

Interventions

enoxaparin sodium 1 apixaban 1 Rivaroxaban 1 Heparin, Low-Molecular-Weight 1 Enoxaparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07270263 2025-12-26

HEM-DOAC

Medical University of Gdansk

Phase NA Recruiting

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Hematologic Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡